Tess Thompson, research assistant professor at the Brown School at Washington University in St. Louis, has received a five-year grant from the National Cancer Institute of the National Institutes of Health (NIH) to study unmet social needs of cancer patients and their caregivers, with the ultimate aim of improving outcomes for both.
A new study led by the School of Medicine reveals at least one cause of low white blood cell counts in patients treated for glioblastoma and demonstrates a potential treatment strategy that improves survival in mice.
Researchers at the School of Medicine have identified a previously unknown signaling pathway cells use to protect their DNA while it is being copied. The findings suggest a way that could boost the potency of cancer therapeutics.
A new study by researchers at Washington University School of Medicine found that the quality of care for lung cancer in the U.S. varies widely. The findings show that high-quality care is associated with improved overall survival rates among patients with lung cancer.
A study from Washington University School of Medicine suggests a strategy for preventing a chronic, slow-growing type of blood cancer from progressing to an aggressive form of leukemia.
Abhinav Jha, at the McKelvey School of Engineering, wants to use novel imaging to better understand how people absorb radiation therapy. His team won a four-year $2.2 million National Institutes of Health (NIH) grant for the study, which aims to guide treatment decisions.
A nationwide team studied 44,000 smokers at 28 cancer centers, including Siteman Cancer Center, and learned that if they could get such patients into nicotine replacement, counseling or both, they could help nearly one in five quit smoking, while also boosting cancer survival rates.
Research from Quing Zhu’s lab at the McKelvey School of Engineering yields a novel method to use ultrasound to enhance machine learning’s ability to accurately diagnose — or rule out — ovarian cancer.
A new study by researchers at Washington University School of Medicine found that undergoing more frequent computed tomography (CT) scans was not associated with improved outcomes following lung cancer surgery.
A drug compound attacks hard-to-treat prostate cancer on several fronts, according to a School of Medicine study in mice and human cells. It triggers immune cells to attack, helps the immune cells penetrate the tumor and cuts off the tumor’s ability to burn testosterone as fuel.